Medicare Group Q.P.S.C. (MCGS.QA)
Doha, QA
Operating from its base in Doha, Qatar, Medicare Group Q.P.S.C. delivers an extensive range of healthcare and medical treatment services throughout the country. The company's portfolio includes the management of hospitals, various medical clinic centers, and outpatient facilities. Furthermore, it provides specialized provisions such as home nursing care, physical therapy, and nutritional counseling. Founded in 1996, the organization was previously known as Al Ahli Specialised Hospital Company Q.P.S.C.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.18% | -0.68% | +0.04% | +10.44% | -13.18% | -16.71% | +10.66% | -19.74% | -41.26% | -45.86% | +170.69% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%-4.0% Q1'26: -12.9% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+28.6% ★ Q1'26: -53.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+10.4% Q1'26: +23.5% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+12.7% ★ Q1'26: +5.2% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+5.7% Q1'26: +2.1% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.66× ★ Q1'26: 2.83× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
490.68M
est: 490.68M (+0.0%)
|
476.80M
est: 421.86M (+13.0%)
|
481.75M
est: 467.20M (+3.1%)
|
487.17M
est: 491.80M (-0.9%)
|
486.31M
est: 485.91M (+0.1%)
|
523.49M
est: 521.91M (+0.3%)
|
502.60M
est: 519.20M (-3.2%)
|
474.06M
474.06M – 474.06M
-8.7% YoY
|
675.18M
675.18M – 675.18M
+42.4% YoY
|
812.14M
812.14M – 812.14M
+20.3% YoY
|
853.83M
853.83M – 853.83M
+5.1% YoY
|
| EBITDA |
110.60M
est: 109.50M (+1.0%)
|
117.47M
est: 94.14M (+24.8%)
|
111.77M
est: 104.26M (+7.2%)
|
110.75M
est: 109.75M (+0.9%)
|
96.85M
est: 108.44M (-10.7%)
|
110.42M
est: 109.51M (+0.8%)
|
90.34M
est: 108.95M (-17.1%)
|
99.47M
99.47M – 99.47M
-8.7% YoY
|
141.68M
141.68M – 141.68M
+42.4% YoY
|
170.41M
170.41M – 170.41M
+20.3% YoY
|
179.16M
179.16M – 179.16M
+5.1% YoY
|
| EBIT |
82.15M
est: 81.67M (+0.6%)
|
88.87M
est: 70.21M (+26.6%)
|
82.20M
est: 77.76M (+5.7%)
|
81.23M
est: 81.85M (-0.8%)
|
68.84M
est: 80.87M (-14.9%)
|
83.81M
est: 80.43M (+4.2%)
|
63.94M
est: 80.01M (-20.1%)
|
73.06M
73.06M – 73.06M
-8.7% YoY
|
104.05M
104.05M – 104.05M
+42.4% YoY
|
125.16M
125.16M – 125.16M
+20.3% YoY
|
131.58M
131.58M – 131.58M
+5.1% YoY
|
| Net Income |
78.20M
est: 78.80M (-0.8%)
|
85.51M
est: 67.55M (+26.6%)
|
79.06M
est: 78.80M (+0.3%)
|
79.16M
est: 82.21M (-3.7%)
|
65.70M
est: 76.27M (-13.9%)
|
60.06M
est: 63.61M (-5.6%)
|
76.01M
est: 87.25M (-12.9%)
|
67.55M
67.55M – 67.55M
-22.6% YoY
|
149.16M
149.16M – 149.16M
+120.8% YoY
|
146.35M
146.35M – 146.35M
-1.9% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
17.29M
est: 29.89M (-42.2%)
|
14.22M
est: 25.70M (-44.7%)
|
13.52M
est: 28.46M (-52.5%)
|
14.47M
est: 29.96M (-51.7%)
|
85.55M
est: 29.60M (+189.0%)
|
21.49M
est: 48.82M (-56.0%)
|
96.96M
est: 48.56M (+99.7%)
|
44.34M
44.34M – 44.34M
-8.7% YoY
|
63.15M
63.15M – 63.15M
+42.4% YoY
|
75.96M
75.96M – 75.96M
+20.3% YoY
|
79.86M
79.86M – 79.86M
+5.1% YoY
|
| EPS |
0.28
est: 0.28 (+0.0%)
|
0.30
est: 0.24 (+25.0%)
|
0.28
est: 0.28 (+0.0%)
|
0.28
est: 0.29 (-4.1%)
|
0.23
est: 0.27 (-15.1%)
|
0.21
est: 0.23 (-7.1%)
|
0.27
est: 0.31 (-12.9%)
|
0.24
0.24 – 0.24
-22.6% YoY
|
0.53
0.53 – 0.53
+120.8% YoY
|
0.52
0.52 – 0.52
-1.9% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-25 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-24 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-17 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-10 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-03 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-26 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-19 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Qatar ETF QAT | 0.83% | 543.9K | 0.60% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.03% | 31.8K | 0.42% |
| 3 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 137.1K | 0.46% |
| 4 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 19.3K | 0.56% |
| 5 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.01% | 23.4K | 0.33% |
| 6 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 32.4K | 0.44% |
| 7 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 452.2K | 0.39% |
| 8 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 409.9K | 0.29% |
| 9 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 157.8K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jamal Saleh Abdul Khaleq | Deputy Chief Executive Officer | — | — |
| Khalid Abdulla Bin Thani Bin Abdulla Al-Thani | MD & Non Independent Vice Chairman | — | — |
| Khalid Mohammed Al-Emadi | Chief Executive Officer | — | male |
| Sheikh Khalid Bin Khalifa Al-Thani | Deputy Chairman | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MCGS.QA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
